Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

  • Nat Genet. 2004 Dec;36(12):1319-25. doi: 10.1038/ng1479.
Elisabeth B Binder  1 Daria Salyakina Peter Lichtner Gabriele M Wochnik Marcus Ising Benno Pütz Sergi Papiol Shaun Seaman Susanne Lucae Martin A Kohli Thomas Nickel Heike E Künzel Brigitte Fuchs Matthias Majer Andrea Pfennig Nikola Kern Jürgen Brunner Sieglinde Modell Thomas Baghai Tobias Deiml Peter Zill Brigitta Bondy Rainer Rupprecht Thomas Messer Oliver Köhnlein Heike Dabitz Tanja Brückl Nina Müller Hildegard Pfister Roselind Lieb Jakob C Mueller Elin Lõhmussaar Tim M Strom Thomas Bettecken Thomas Meitinger Manfred Uhr Theo Rein Florian Holsboer Bertram Muller-Myhsok
Affiliations
  • 1. Max-Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany. [email protected]
Abstract

The stress hormone-regulating hypothalamic-pituitary-adrenal (HPA) axis has been implicated in the causality as well as the treatment of depression. To investigate a possible association between genes regulating the HPA axis and response to antidepressants and susceptibility for depression, we genotyped single-nucleotide polymorphisms in eight of these genes in depressed individuals and matched controls. We found significant associations of response to antidepressants and the recurrence of depressive episodes with single-nucleotide polymorphisms in FKBP5, a glucocorticoid receptor-regulating cochaperone of hsp-90, in two independent samples. These single-nucleotide polymorphisms were also associated with increased intracellular FKBP5 protein expression, which triggers adaptive changes in Glucocorticoid Receptor and, thereby, HPA-axis regulation. Individuals carrying the associated genotypes had less HPA-axis hyperactivity during the depressive episode. We propose that the FKBP5 variant-dependent alterations in HPA-axis regulation could be related to the faster response to antidepressant drug treatment and the increased recurrence of depressive episodes observed in this subgroup of depressed individuals. These findings support a central role of genes regulating the HPA axis in the causality of depression and the mechanism of action of antidepressant drugs.